In daily pediatric practice, shared decision-making is already happening, often more than is acknowledged,” a pediatrician ...

European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...

The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...

First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous funding environment ...

The proposal would mark a significant change for the secretive PBM industry, which often shields crucial data from its clients.

Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work ...

A majority of respondents (67%) say Congress did the “wrong thing” by not yet extending the ACA enhanced premium tax credits, though judgement fell largely across party lines. While 89% of Democrats ...

A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...

AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development ...

Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...

The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...

As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.